European startups are increasingly turning to the UK as a strategic base for scaling globally, driven by a supportive ecosystem and robust government initiatives. The reformed Office for Investment and National Wealth Fund have spurred over £70bn in private investment, positioning the UK as a top destination for tech innovation. For firms like French biotech giant Aqemia, establishing a London office was pivotal: “The decision was driven by the ecosystem density and access to global pharmaceutical networks,” said CEO Maximilien Levesque.

Similarly, workflow automation platform N8n cited the UK’s talent pool as key, with VP Claudia Stiefel noting, “London’s depth of skilled workers and investor access made it unmatched.”.